NEW YORK, July 28, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today the opening of its SL-401 Investigational New Drug (IND) and initiation of a broad clinical development program including trials in blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute myeloid leukemia (AML). SL-401 is a targeted therapy directed to the interleukin-3 receptor (IL-3R) present on cancer stem cells (CSCs) and tumor bulk of many hematologic cancers.
WWE® Chief Brand Officer Stephanie McMahon has been selected as a 2015
Eisenhower USA Fellow, one of nine U.S. leaders to participate in the
prestigious international leadership exchange program for outstanding
professionals, the Eisenhower Fellowships announced today.
ST. LOUIS, July 28, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2014 second quarter ended June 30, 2014 on Monday, August 4, 2014 after the close of the U.S. financial markets.
MONTEBELLO, NY--(Marketwired - October 27, 2014) - Sterling Bancorp (NYSE: STL), the parent company of Sterling National Bank, today announced that the Board of Directors has declared a quarterly cash dividend of $0.07 per share.
MONTEBELLO, NY--(Marketwired - October 01, 2014) - Sterling Bancorp (NYSE: STL), the parent company of Sterling National Bank, today announced that it plans to release results for the fourth quarter and full-year fiscal 2014 after the market close on Monday, October 27, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.